Search Results - "NODE, K"

Simvastatin Decreases IL-6 and IL-8 Production in Epithelial Cells by Sakoda, K., Yamamoto, M., Negishi, Y., Liao, J.K., Node, K., Izumi, Y.

“…Many cardiovascular studies have suggested that 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitors (statins) have anti-inflammatory effects…”
Get full text

Comparison of SGLT2 inhibitors vs. DPP4 inhibitors for patients with metabolic dysfunction associated fatty liver disease and diabetes mellitus by Suzuki, Y., Kaneko, H., Okada, A., Ohno, R., Yokota, I., Fujiu, K., Jo, T., Takeda, N., Morita, H., Node, K., Yasunaga, H., Komuro, I.

“…Purpose This study aimed to examine the potential benefit of sodium-glucose cotransporter 2 (SGLT2) inhibitors for patients with metabolic…”
Get full text

Involvement of the PI3K/AKT Pathway in the Formation and Fusion of Spheroids Derived from Human Dermal Fibroblast for Tissue Engineering Technology by Amamoto, S., Itoh, M., Takahashi, B., Kitsuka, T., Uchihashi, K., Murata, D., Node, K., Nakayama, K., Kamohara, K.

“…Through the biofabrication technology using cellular aggregates (spheroids), an artificial blood vessel derived from autologous cells of human dermal…”
Get full text

Effect of telmisartan on cholesterol levels in patients with hypertension - Saga Telmisartan Aggressive Research (STAR) by Inoue, T, Morooka, T, Moroe, K, Ikeda, H, Node, K

“…Saga Telmisartan Aggressive Research (STAR) is a single-arm, prospective multi-center trial to evaluate the effectiveness of treatment with telmisartan in…”
Get more information

Association of -786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance by OHTOSHI, K, YAMASAKI, Y, GOROGAWA, S, HAYAISHI-OKANO, R, NODE, K, MATSUHISA, M, KAJIMOTO, Y, HORI, M

“…Endothelial derived nitric oxide synthase ( eNOS) gene polymorphisms affect eNOS activity and are associated with abnormal vasomotility and impaired local…”
Get full text

Development of 3-Dimensional Prevascularized Scaffold-Free Contractile Cardiac Patch for Heart Regeneration by Noguchi, R, Nakayama, K, Itoh, M, Kamohara, K, Furukawa, K, Oyama, J, Node, K, Morita, S

“…Purpose The aim of our study is to develop completely scaffold-free, viable, contractile cardiac tissue which can be grafted to the damaged native heart…”
Get full text

Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan by Inoue, T., Taguchi, I., Abe, S., Toyoda, S., Sakuma, M., Node, K.

“…Summary What is known and objective:  Telmisartan, an angiotensin II type 1 receptor blocker (ARB), acts as a partial agonist for peroxisome…”
Get full text

Sulfatides are associated with neointimal thickening after vascular injury by Inoue, T, Taguchi, I, Abe, S, Li, G, Hu, R, Nakajima, T, Hara, A, Aoyama, T, Kannagi, R, Kyogashima, M, Node, K

“…Abstract Background Sulfatides are known to be a native ligand of P-selectin. Platelet-leukocyte interaction via the cross-talk between P-selectin and…”
Get full text

66 Fabrication of Engineered Pulsatile 3-Dimensional Scaffold-Free Cardiac Tissue from Embryonic Stem Cells by Noguchi, R, Nakayama, K, Ishihara, K, Murata, Y, Node, K, Morita, S

“…Purpose Transplantation of healthy regenerative cardiomyocytes into the injured heart is effective option to improve cardiac function. The optimal…”
Get full text

Reversible primary hypothyroidism in Japanese patients undergoing maintenance hemodialysis by Sanai, T, Inoue, T, Okamura, K, Sato, K, Yamamoto, K, Abe, T, Node, K, Tsuruya, K, Iida, M

“…The presence or absence of hypothyroidism was assessed in 152 consecutive Japanese patients with end-stage renal disease on hemodialysis. Eight patients who…”
Get more information

Additional renoprotective effects of azelnidipine combined with angiotensin receptor blockers in patients with diabetic nephropathy by Nakamura, T, Inoue, T, Fujiwara, N, Kawagoe, Y, Sugaya, T, Ueda, Y, Koide, H, Node, K

“…Azelnidipine has been reported to have antioxidant effects and attenuates tubulointerstitial ischemia. The aim of the present study was to determine whether…”
Get more information

Prognostic impact of initial serum albumin for newly developing heart failure after acute myocardial infarction by Shinzato, K, Yoshioka, G, Watanabe, N, Shibata, Y, Node, K

Get full text

Long-year follow-up of acute myocardial infarction with preserved initial LVEF: prognostic impact of progressively reduced LVEF by Yoshioka, G, Watanabe, N, Shibata, Y, Node, K

Get full text

Clinical impact of CREDO-kyoto risk score on in-hospital bleeding in patients with acute coronary syndrome by Minematsu, Y, Natsuaki, M, Yoshioka, G, Shinzato, K, Nishimura, Y, Nishikido, T, Node, K

Get full text

Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts by Shiraki, A, Oyama, J, Shimizu, T, Nakajima, T, Yokota, T, Node, K

Get full text

Temporary acidosis during reperfusion limits myocardial infarct size in dogs by Kitakaze, M, Takashima, S, Funaya, H, Minamino, T, Node, K, Shinozaki, Y, Mori, H, Hori, M

“…We tested the hypothesis that myocardial extracellular acidosis during early reperfusion limits infarct size. The left anterior descending coronary artery was…”
Get full text

P894Losing body weight is a strong independent predictor of rehospitalization and prognosis in patients with heart failure by Nishikido, T, Oyama, J, Nagatomo, D, Shiraki, A, Node, K

Get full text

P6440Mid-term outcomes of second-generation drug-eluting-stent implantation for left main coronary artery disease compare with first-generation drug-eluting-stent by Yoshioka, G, Kuriyama, N, Nishino, S, Node, K, Shibata, Y

Get full text

P5383The coronary collateral development by angiogenesis of COA-Cl (2-Cl-C.OXT-A) in myocardial infarction by Nishikido, T., Oyama, J., Tsukamoto, I., Igarashi, J., Node, K.

Get full text

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial by Colhoun, Helen M., Lingvay, Ildiko, Brown, Paul M., Deanfield, John, Brown-Frandsen, Kirstine, Kahn, Steven E., Plutzky, Jorge, Node, Koichi, Parkhomenko, Alexander, Rydén, Lars, Wilding, John P. H., Mann, Johannes F. E., Tuttle, Katherine R., Idorn, Thomas, Rathor, Naveen, Lincoff, A. Michael

“…The SELECT trial previously reported a 20% reduction in major adverse cardiovascular events with semaglutide ( n  = 8,803) versus placebo ( n  = 8,801) in…”
Get full text